A New Alzheimer's Drug Comes With Lots Of Questions About How To Use It
Weeks after the Food and Drug Administration approved the Alzheimer's drug Aduhelm, doctors are struggling to figure out who should get the drug and how to use it safely.
Nearly two months after the Alzheimer's drug Aduhelm received conditional approval from the Food and Drug Administration, experts are still debating how, and whether, it should be used.
A few doctors and medical institutions say they have no plans to administer Aduhelm. Many more are trying to decide which patients should have access to the drug, and how to protect them from its potentially dangerous side effects.
Alzheimer's is "an incurable condition and it's progressive," says , who directs the Banner
